Stock Taper
EARNINGS CALL ARCHIVE 1 CALL ON FILE
ENTX — Entera Bio Ltd.
NASDAQ
FULL STOCK PAGE →

Q1 2022 Earnings Call Summary

MAY 18, 2022
REVENUE
$68000 -58.8%
NET MARGIN
-5564.7% -8544.1 PTS
EPS
-$0.13 -112.7%
FREE CASH FLOW
-$4.8M -80.5%

No summary has been written for this call yet.